uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted October 18, 2016

Seller of Sublingual Vitamins Warned for Drug Claims

On August 31, 2016, the FDA issued a warning letter to Bio-Stasis International, Inc., following a review of the company's website which found statements made about its sublingual tablets, ViraPress, Vitamin D-3 and Vitamin B-12. to be drug claims.

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at